title: Radiation dosimetry of 82Rb in humans under pharmacologic stress.
abstract: (82)Rb is used with PET for cardiac perfusion studies. Using human biokinetic measurements, in vivo, we recently reported on the resting-state dosimetry of this agent. The objective of this study was to obtain (82)Rb dose estimates under stress.
  
  
  METHODS
  (82)Rb biokinetics were obtained in 10 healthy volunteers (5 male, 5 female; mean age ± SD, 33 ± 10 y; age range, 18-50 y) using whole-body PET/CT. The 76-s half-life of (82)Rb and the corresponding need for pharmacologic vasodilation require that all imaging be completed within 10 min. To accommodate these constraints, while acquiring the data needed for dosimetry we used the following protocol. First, a whole-body attenuation correction CT scan was obtained. Then, a series of 3 whole-body PET scans was acquired after a single infusion of 1.53 ± 0.12 GBq of (82)Rb at rest. Four minutes after the infusion of a 0.56 mg/kg dose of the vasodilator, dipyridamole, 3 serial whole-body PET scans were acquired after a single infusion of 1.50 ± 0.16 GBq of (82)Rb under stress. The time-integrated activity coefficient (TIAC) for stress was obtained by scaling the mean rest TIAC obtained from our previous rest study by the stress-to-rest TIAC ratio obtained from the rest-stress measurements described in this report.
  
  
  RESULTS
  The highest mean organ-absorbed doses under stress were as follows: heart wall, 5.1, kidneys, 5.0, lungs, 2.8, and pancreas, 2.4 μGy/MBq (19, 19, 10.4, and 8.9 mrad/mCi, respectively). The mean effective doses under stress were 1.14 ± 0.10 and 1.28 ± 0.10 μSv/MBq using the tissue-weighting factors of the International Commission on Radiological Protection, publications 60 and 103, respectively.
  
  
  CONCLUSIONS
  Appreciable differences in source-organ biokinetics were observed for heart wall and kidneys during stress when compared with the previously reported rest study. The organ receiving the highest dose during stress was the heart wall. The mean effective dose calculated during stress was not significantly different from that obtained at rest.
authors.affiliation: Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD, USA.
authors.forename: Srinivasan
authors.initials: S
authors.lastname: Senthamizhchelvan
authors.forename: Paco E
authors.initials: PE
authors.lastname: Bravo
authors.forename: Martin A
authors.initials: MA
authors.lastname: Lodge
authors.forename: Jennifer
authors.initials: J
authors.lastname: Merrill
authors.forename: Frank M
authors.initials: FM
authors.lastname: Bengel
authors.forename: George
authors.initials: G
authors.lastname: Sgouros
mesh_terms: D000293:Adolescent; D000328:Adult; D004176:Dipyridamole; D005080:Exercise Test; D005260:Female; D006801:Humans; D008297:Male; D008657:Metabolic Clearance Rate / Q000187:drug effects; D008875:Middle Aged; D009928:Organ Specificity / Q000187:drug effects; D011829:Radiation Dosage; D019275:Radiopharmaceuticals / Q000008:administration & dosage / Q000493:pharmacokinetics; D012016:Reference Values; D012414:Rubidium Radioisotopes / Q000008:administration & dosage / Q000493:pharmacokinetics*; D014018:Tissue Distribution / Q000187:drug effects; D014665:Vasodilator Agents; D014915:Whole-Body Counting; D055815:Young Adult
chemical_list: D019275:Radiopharmaceuticals; D012414:Rubidium Radioisotopes; D014665:Vasodilator Agents; D004176:Dipyridamole